News EMA Panel Backs Netarsudil for Elevated Intraocular Pressure by Medscape • 2019/09/20 • 0 Comments An EMA advisory panel recommended marketing authorization for netarsudil ophthalmic solution 0.02% for the treatment of adults with glaucoma or ocular hypertension. International Approvals Full Story →